Latest Information
Brain Navi Biotechnology announced that its single-use neuroendoscope, KrystoLens, has officially received TFDA certification.
NaoTrac neurosurgical navigation robot has officially received medical device approval from India’s CDSCO.
The KrystoLens wins the “Innovative Medical Devices and Diagnostic Technology Award" under the 22nd National Innovation Awards.
We’re excited to share that Brain Navi will be exhibiting at several major international events in the second half of the year, including Medical Fair Asia Thailand, Medical Japan, EANS Vienna, and MEDICA Düsseldorf.
Brain Navi Biotechnology has officially entered the Spanish market, completing its first NaoTrac-assisted neurosurgeries in collaboration with Palex Healthcare.
In collaboration with Palex Healthcare, we introduce NaoTrac, the advanced neurosurgical navigation robot enhancing precision and safety. Join us in SENEC as we support innovation and excellence in Spanish neurosurgery.
Brain Navi Biotechnology has announced a strategic partnership with BenQ Medical Technology to introduce and commercialize the NaoTrac neurosurgical navigation robot in the Chinese market.
Brain Navi is joining AANS 2025 for the first time, bringing NaoTrac, our Surgical navigation robot, closer to the U.S. neurosurgery market.
Precision and minimally invasive are more than technical goals—they are a pledge to uphold patient dignity. In the high-stakes realm of neurosurgery, where the brain’s complexity leaves only a millimeter of room for error, the demand for perfection is redefining the future of medical innovation.
These heart-wrenching words came from the family of a 56-year-old patient. A sudden fall in the bathroom led to a severe brain stroke.
Today’s neurosurgical navigation systems face critical limitations that continue to challenge surgeons and OR teams alike. From slow workflows to registration inaccuracies, these pain points can directly impact surgical precision and patient safety.
Dr. Hao-Yu Chuang's team used NaoTrac for stereotactic brain surgeries, achieving high accuracy in tumor biopsies and ICH drainage. The results were recognized at AANS.
